TXN
Status-Quo-PlayerTexas Instruments
$216.71
+0.95%
as of 13 Apr
Power Core
Power Core in one sentence: TXN's moat is the intersection of 300mm manufacturing cost leadership with an 80,000-SKU product catalog that collectively creates a position no competitor can profitably attack at scale.
Direction of Movement
Capex Peak Passing, Awaiting the Demand Inflection
ROC 200
-2.2%
Direction Signals
- Signal 1: 300mm capacity ramp reaching inflection. By 2026, TXN's RFAB2 is in volume production, LFAB is ramping, and the first phase of the Sherman complex is approaching initial production readiness. The company has indicated that incremental revenue generated on 300mm capacity carries structurally higher gross margins than legacy 200mm production. As revenue begins to flow through the new fabs, the margin expansion potential is significant, but only if utilization rates rise. Through early 2026, utilization at the newer facilities remains below optimal levels, with management guiding for gradual ramp through 2027 and 2028. The capex peak has likely passed, with capital spending expected to moderate from 2025 levels, which should allow free cash flow to recover. The math is straightforward: if analog demand grows at a mid-single-digit CAGR and TXN holds or gains share, the new capacity will be absorbed and margins will expand. If demand disappoints, depreciation headwinds persist.
- Signal 2: Automotive content per vehicle continues to rise, providing a secular tailwind. Industry data from Strategy Analytics and Gartner indicates that average semiconductor content per vehicle, including analog content specifically, continues to increase in both internal combustion and electric architectures. TXN's automotive revenue grew at a double-digit CAGR from 2018 through 2023 before normalizing during the inventory correction. Design-in activity in automotive, as measured by TXN's new product introductions and qualification rates for AEC-Q100 grade components, remains robust through early 2026. The automotive end market's structural growth trajectory supports TXN's capacity investment thesis, though the timing of volume ramp remains uncertain given macroeconomic and EV adoption variability.
- Signal 3: Competitive attrition in second-tier analog suppliers. Several smaller Western analog companies have struggled to maintain margin and market relevance in the face of TXN's cost advantage and Chinese competition from below. Microchip Technology's analog segment, for instance, has underperformed, and the general trend in the industry is toward consolidation or strategic retreat from commodity analog segments. This competitive attrition works in TXN's favor over time, as customers who lose a second-source supplier for a particular analog function tend to consolidate toward TXN's broader catalog. The long-term share gain dynamic from industry rationalization is observable in the data: TXN's analog market share has grown from approximately 15% in 2015 to roughly 19% by 2025.
- Signal 4: CHIPS Act funding and investment tax credits de-risk the capex cycle. TXN's preliminary awards under the CHIPS Act, including both direct grants and the 25% investment tax credit for semiconductor manufacturing, reduce the effective cost of the Sherman buildout by a material amount. While the political durability of these incentives is not guaranteed beyond the current legislative framework, the subsidies that have already been committed or disbursed meaningfully improve the return profile of TXN's capacity investments. This de-risking of the capex cycle is not fully reflected in many valuation models that were constructed before CHIPS Act terms were finalized.
Texas Instruments is the rare semiconductor company that has made a deliberate, decades-long strategic choice to be boring. While the broader chip industry chases the bleeding edge of process geometry, artificial intelligence accelerators, and hyperscaler design wins, TXN has built an empire on analog and embedded processing chips, the unglamorous circuitry that converts real-world signals into digital data and manages power in virtually every electronic device on Earth. This is not a company that disrupts. This is a company that makes disruption irrelevant to its core business.
The central analytical question for TXN in 2026 is not whether its products matter, because they clearly do, appearing in everything from automotive ECUs to industrial robots to medical devices. The question is whether the company's unprecedented capital expenditure cycle, a multi-year buildout of 300mm wafer fabrication capacity that began with the RFAB2 and LFAB expansions and continued with the massive Sherman, Texas greenfield fabs, will generate returns commensurate with the capital deployed, or whether TXN has overbuilt into a structural demand environment that is shifting beneath it.
Here is the observation that standard financial models miss: TXN's capex program is not primarily a capacity play. It is a pricing power play disguised as a manufacturing investment. By vertically integrating into 300mm production for analog chips, a domain where most competitors rely on older, less efficient 200mm fabs or outsource to foundries, TXN is engineering a cost advantage that compounds over time. Each incremental wafer produced on 300mm equipment carries roughly 40% more die per wafer than 200mm equivalents, at marginally lower per-unit cost. The company is not building fabs to meet demand. It is building fabs to make its cost position so dominant that competitors gradually cede margin, then market share, then relevance. The parallel to Intel's fab strategy in the 1990s microprocessor era is instructive, but the difference is that TXN operates in a market with tens of thousands of SKUs and no single customer large enough to exert countervailing leverage. This makes the strategy harder to observe and harder to counter.
TXN's 2025 revenue base of approximately $16 to $17 billion, with analog representing roughly 75% and embedded processing roughly 20%, places it at the nexus of the industrial, automotive, and personal electronics supply chains. The company has navigated the post-pandemic semiconductor inventory correction and now sits at an inflection point where the capex cycle either validates management's multi-decade thesis or burdens the company with excess depreciation for years to come.
This analysis continues with 6 more sections.
Continue reading: Role Assignment · Strategic Environment · Dependency Matrix · Self-Image & Mission · Direction of Movement · Portfolio Lens
Read full analysis — freeCreate a free account. No credit card. No trial period.